Quintrio
Home

SERVICES-EDUCATIONAL SERVICES

Covista Inc.

CVSA

Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.

Last trade $118.05
Day change +$0.31 (+0.26%)
Day range $116.80 – $119.35
Volume 116,675
Market cap $3.92B

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$3.92B
Price / earnings
15.23×
Price / book
2.75×
Price / sales
1.95×
EV / sales
2.09×
EV / EBITDA
9.19×

Profitability

Earnings per share
$7.73
Return on assets
8.78%
Return on equity
18.09%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.35×
Current ratio
0.81×
Quick ratio
0.81×
Cash ratio
0.32×

Cash flow

Price / cash flow
8.63×
Price / free cash flow
11.04×
Free cash flow
$354.65M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for CVSA, quarterly periods
Line itemQ1 FY2027 Sep 30, 2026Q4 FY2026 Jun 30, 2026Q3 FY2026 Mar 31, 2026
Revenue$511.53M$501.38M$487.03M
Cost of revenue$220.76M$216.75M$210.72M
Gross profit$290.78M$284.63M$276.31M
Selling, general and administrative$192.59M$188.09M$184.11M
Research and development$0$0$0
Total operating expenses$192.75M$189.19M$184.97M
Operating income$98.03M$95.44M$91.34M
Interest expense-$9.94M-$9.8M-$13.63M
Income before taxes$89.5M$88.4M$77.95M
Income taxes$18.02M$16.24M$19.96M
Net income$66.06M$66.29M$41.64M
Net income attributable to common shareholders$67.43M$71.72M$41.64M
EBITDA$110.45M$110.57M$106.39M
Basic earnings per share$1.99$2.11$1.21
Diluted earnings per share$1.95$2.06$1.20

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Here's Why Covista (CVSA) is a Strong Growth Stock

Covista Inc. (CVSA), formerly Adtalem Global Education, is highlighted as a stock to watch with a Zacks Rank #2 (Buy) rating and VGM Score of A. The company, America's largest healthcare educator serving over 100,000 students, shows strong growth potential with forecasted year-over-year earnings growth of 9.8% for the current fiscal year and recent upward earnings estimate revisions.

Zacks Investment Research

Covista (CVSA) Beats Q1 Earnings and Revenue Estimates

Covista (CVSA) reported quarterly earnings of $2.19 per share, beating consensus estimates of $1.90 and representing a 15.26% earnings surprise. The company also exceeded revenue expectations with $511.53 million. However, the stock received a Zacks Rank #3 (Hold) rating with mixed estimate revisions. Meanwhile, peer McGraw Hill (MH) is expected to report a 47.9% year-over-year earnings decline when it releases results on November 5.

Zacks Investment Research

Why Covista (CVSA) is a Top Momentum Stock for the Long-Term

Zacks Premium offers investment research tools including Style Scores that rate stocks based on value, growth, and momentum characteristics. The Zacks Rank system has historically outperformed the S&P 500 with an average annual return of +23.82% since 1988. Covista Inc. (CVSA), a healthcare education company, is highlighted as a stock to watch with a #3 Hold rank and VGM Score of A.

Zacks Investment Research

Why Covista (CVSA) is a Top Growth Stock for the Long-Term

Covista Inc. (CVSA), America's largest healthcare educator serving over 100,000 students, is highlighted as a stock to watch. The company holds a #3 (Hold) Zacks Rank with an A VGM Score and A Growth Style Score, forecasting 9.1% year-over-year earnings growth for the current fiscal year. With recent analyst upgrades and an average earnings surprise of +11.7%, CVSA presents solid growth potential for investors.

The Motley Fool

Covista Chairman & CEO Sells About 5,300 Shares Near 8-Month High Price

Covista Inc. Chairman and CEO Stephen W. Beard sold 5,291 shares on June 10-11, 2026, for approximately $690,000 near an 8-month high price. The sale was executed under a predefined trading plan and represented excess holdings above company requirements. While Beard maintains over $55 million in direct equity, the timing of the sale near peak prices raises questions about executive confidence in the company's near-term prospects.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Dec 17, 20043-for-1forward split